NFG
IRD

Next Financial Group’s Opus Genetics IRD Stock Holding History

Next Financial Group’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
41
– – ﹤0.01% 3002
2021
Q3 		$0 Hold
41
– – ﹤0.01% 2827
2021
Q2 		$0 Hold
41
– – ﹤0.01% 2734
2021
Q1 		$0 Hold
41
– – ﹤0.01% 2651
2020
Q4 		$0 Sell
41
-1
-2% -$7 ﹤0.01% 2431
2020
Q3 		$0 Buy
+42
New +$409 ﹤0.01% 2226
2020
Q2 		– Sell
-42
Closed – – 1935
2020
Q1 		$0 Hold
42
– – ﹤0.01% 2451
2019
Q4 		$0 Hold
42
– – ﹤0.01% 2549
2019
Q3 		$0 Buy
+42
New +$584 ﹤0.01% 2449

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Next Financial Group's IRD Position: Q4 2021 in Review

Next Financial Group held its Opus Genetics (IRD) position steady in Q4 2021 at 41 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3002.

Next Financial Group first reported a position in IRD in Q3 2019 and has held it in 9 quarters since. 40 funds tracked by Wall St. Rank hold IRD as of Q4 2021.

  • Next Financial Group held 41 shares of Opus Genetics worth $0 as of Q4 2021.
  • Next Financial Group left its Opus Genetics share count unchanged in Q4 2021.
  • Opus Genetics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #3002 holding.
  • Next Financial Group first reported a position in Opus Genetics in Q3 2019 and has held it in 9 quarters since.
  • 40 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.